Abstract
The present study aimed to determine the semen quality and cryopreservation outcomes among adolescent transgender females at the time of fertility preservation (FP) before initiating gender-affirming hormone (GAH) treatment. This retrospective cohort study included 26 adolescent transgender females who underwent FP in our Fertility Institute between 06/2013 and 10/2020. Pre-freezing semen parameters were compared to WHO 2010 reference values. Post-thaw semen parameters were used to determine the adequate assisted reproductive technology (ART). A multivariate linear regression analysis was performed to assess the impact of medical and lifestyle factors on semen quality. The mean age at which adolescent transgender females underwent FP was 16.2 ± 1.38 years. The median values of all semen parameters in our study group were significantly lower compared to the WHO data, including volume (1.46 mL vs 3.2 mL, respectively, P = 0.001 ), sperm concentration (28 × 106/mL vs 64 × 106/mL, P < 0.001), total sperm number (28.2 × 106 vs 196 × 106, P < 0.001), total motility (51.6% vs 62%, P < 0.001), and normal morphology (2% vs 14%, P < 0.001). The frequency of semen abnormalities was teratozoospermia 72%, hypospermia 52%, oligozoospermia 28%, and azoospermia 4%. The median post-thaw total motile count was 0.17 × 106/vial, and the quality was adequate only for ICSI in 87.7% of the thawed semen samples. No correlation was found between selected medical and lifestyle factors and poor semen parameters. Semen quality is strongly reduced among adolescent transgender females before hormone therapy and their stored sperm samples are suitable for intracytoplasmic sperm injection (ICSI) rather than conventional IVF/intrauterine insemination (IUI).
Similar content being viewed by others
References
Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend. 2012;13:165–232.
Murad MH, Elamin MB, Garcia MZ, Mullan RJ, Murad A, Erwin PJ, et al. Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol. 2010;72:214–31.
Edwards-Leeper L, Spack NP. Psychological evaluation and medical treatment of transgender youth in an interdisciplinary "Gender Management Service" (GeMS) in a major pediatric center. J Homosex. 2012;59:321–36.
Olson J, Schrager SM, Belzer M, Simons LK, Clark LF. Baseline physiologic and psychosocial characteristics of transgender youth seeking care for gender dysphoria. J Adolesc Health. 2015;57:374–80.
Kreukels BP, Haraldsen IR, De Cuypere G, Richter-Appelt H, Gijs L, Cohen-Kettenis PT. A European network for the investigation of gender incongruence: the ENIGI initiative. Eur Psychiatry. 2012;27:445–50.
Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102:3869–903.
Schneider F, Kliesch S, Schlatt S, Neuhaus N. Andrology of male-to-female transsexuals: influence of cross-sex hormone therapy on testicular function. Andrology. 2017;5:873–80.
Matoso A, Khandakar B, Yuan S, Wu T, Wang LJ, Lombardo KA, et al. Spectrum of findings in orchiectomy specimens of persons undergoing gender confirmation surgery. Hum Pathol. 2018;76:91–9.
Schulze C. Response of the human testis to long-term estrogen treatment: morphology of Sertoli cells, Leydig cells and spermatogonial stem cells. Cell Tissue Res. 1988;251:31–43.
Lübbert H, Leo-Rossberg I, Hammerstein J. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male. Fertil Steril. 1992;58:603–8.
Adeleye AJ, Reid G, Kao CN, Mok-Lin E, Smith JF. Semen parameters among transgender women with a history of hormonal treatment. Urology. 2019;124:136–41.
Vereecke G, Defreyne J, Van Saen D, Collet S, Van Dorpe J, T'Sjoen G, et al. Characterisation of testicular function and spermatogenesis in transgender women. Hum Reprod. 2020:deaa254. https://doi.org/10.1093/humrep/deaa254 Online ahead of print.
De Sutter P, Kira K, Verschoor A, Hotimsky A. The desire to have children and the preservation of fertility in transsexual women: a survey. Int J Transgend. 2002;6(3). Retrieved from https://cdn.atria.nl/ezines/web/IJT/9703/numbers/symposion/ijtvo06no03_02.htm
Wierckx K, Van Caenegem E, Pennings G, Elaut E, Dedecker D, Van de Peer F, et al. Reproductive wish in transsexual men. Hum Reprod. 2012;27:483–7.
Auer MK, Fuss J, Nieder TO, Briken P, Biedermann SV, Stalla GK, et al. Desire to have children among transgender people in Germany: a cross-sectional multi-center study. J Sex Med. 2018;15:757–67.
Deutsch MB, Feldman JL. Updated recommendations from the world professional association for transgender health standards of care. Am Fam Physician. 2013;87:89–93.
Ethics Committee of the American Society for Reproductive Medicine. Access to fertility services by transgender persons: an Ethics Committee opinion. Fertil Steril. 2015;104:1111–5.
De Wert G, Dondorp W, Shenfield F, Barri P, Devroey K, Diedrich B, et al. ESHRE Task Force on Ethics and Law 23: medically assisted reproduction in singles, lesbian and gay couples, and transsexual people. Hum Reprod. 2014:291859–65.
De Roo C, Tilleman K, T'Sjoen G, De Sutter P. Fertility options in transgender people. Int Rev Psychiatry. 2016;28:112–9.
Johnson EK, Finlayson C. Preservation of fertility potential for gender and sex diverse individuals. Transgend Health. 2016;1:41–4.
Fernández R, Guillamon A, Cortés-Cortés J, Gómez-Gil E, Jácome A, Esteva I, et al. Molecular basis of Gender Dysphoria: androgen and estrogen receptor interaction. Psychoneuroendocrinology. 2018;98:161–7.
D'Andrea S, Pallotti F, Senofonte G, Castellini C, Paoli D, Lombardo F, et al. Polymorphic cytosine-adenine-guanine repeat length of androgen receptor gene and gender incongruence in trans women: a systematic review and meta-analysis of case-control studies. J Sex Med. 2020;17:543–50.
Li TF, Wu QY, Zhang C, Li WW, Li N, Cui YX, et al. Polymorphisms in estrogen receptors predict the risk of male infertility: a meta-analysis. Reprod Biol Endocrinol. 2014;16:12:79.
Ge YZ, Xu LW, Jia RP, Xu Z, Li WC, Wu R, et al. Association of polymorphisms in estrogen receptor (ESR1 and ESR2) with male infertility: a meta-analysis and systematic review. J Assist Reprod Genet. 2014;31:601–11.
Pan B, Li R, Chen Y, Tang Q, Wu W, Chen L, et al. Genetic association between androgen receptor gene CAG repeat length polymorphism and male infertility: a meta-analysis. Medicine (Baltimore). 2016;95:e2878.
Mobasseri N, Babaei F, Karimian M, Nikzad H. Androgen receptor (AR)-CAG trinucleotide repeat length and idiopathic male infertility: a case-control trial and a meta-analysis. EXCLI J. 2018;17:1167–79.
Sadr M, Khorashad BS, Talaei A, Fazeli N, Hönekopp J. 2D:4D suggests a role of prenatal testosterone in gender dysphoria. Arch Sex Behav. 2020;49:421–32.
Lu H, Huo ZH, Liu YJ, Shi ZY, Zhao JL. Correlations between digit ratio and infertility in Chinese men. Early Hum Dev. 2012;88:865–9.
Akinsal EC, Demirtas A, Ekmekcioglu O. Comparison of the ratio of the length of the second and fourth digits in subgroups of fertile and infertile cases. Urol J. 2017;14:3081–4.
Ricci E, Al Beitawi S, Cipriani S, Candiani M, Chiaffarino F, Viganò P, et al. Semen quality and alcohol intake: a systematic review and meta-analysis. Reprod BioMed Online. 2017;34:38–47.
Sharma R, Harlev A, Agarwal A, Esteves SC. Cigarette smoking and semen quality: a new meta-analysis examining the effect of the 2010 World Health Organization Laboratory Methods for the Examination of Human Semen. Eur Urol. 2016;70:635–45.
Payne KS, Mazur DJ, Hotaling JM, Pastuszak AW. Cannabis and male fertility: a systematic review. J Urol. 2019;202:674–81.
Gollenberg AL, Liu F, Brazil C, Drobnis EZ, Guzick D, Overstreet JW, et al. Semen quality in fertile men in relation to psychosocial stress. Fertil Steril. 2010;9:1104–11.
Li Y, Lin H, Li Y, Cao J. Association between socio-psycho-behavioral factors and male semen quality: systematic review and meta-analyses. Fertil Steril. 2011;95:116–23.
Nordkap L, Jensen TK, Hansen ÅM, Lassen TH, Bang AK, Joensen UN, et al. Psychological stress and testicular function: a cross-sectional study of 1,215 Danish men. Fertil Steril. 2016;105:174–87.
Durairajanayagam D. Lifestyle causes of male infertility. Arab J Urol. 2018;16:10–20.
Zou P, Wang X, Sun L, Chen Q, Yang H, Zhou N, et al. Semen quality in Chinese college students: associations with depression and physical activity in a cross-sectional study. Psychosom Med. 2018;80:564–72.
Nørr L, Bennedsen B, Fedder J, Larsen ER. Use of selective serotonin reuptake inhibitors reduces fertility in men. Andrology. 2016;4:389–94.
Drobnis EZ, Nangia AK. Psychotropics and male reproduction. Adv Exp Med Biol. 2017;1034:63–101.
Coulter RW, Blosnic JR, Bukowski LA, Herrick AL, Siconolfi DE, Stall RD. Differences in alcohol use and alcohol-related problems between transgender- and nontransgender-identified young adults. Drug Alcohol Depend. 2015;154:251–9.
De Freitas LD, Léda-Rêg G, Bezerra-Filho S, Miranda-Scippa Â. Psychiatric disorders in individuals diagnosed with gender dysphoria: a systematic review. Psychiatry Clin Neurosci. 2020;74:99–104.
Raynor PA, Nation A, Outlaw F. Exploring substance use and mental health for minority transgender youth: Implications for advanced practice nurses. J Am Assoc Nurse Pract. 2020;32:229–43.
Mínguez-Alarcón L, Gaskins AJ, Chiu YH, Messerlian C, Williams PL, Ford JB, et al. Type of underwear worn and markers of testicular function among men attending a fertility center. Hum Reprod. 2018;33:1749–56.
Kaya C, Aykaç A, Kaya Y, Taş M. The effect of modifiable lifestyle factors on semen quality. Rev Int Androl. 2020;18:151–8.
Mieusset R, Grandjean H, Mansat A, Pontonnier F. Inhibiting effect of artificial cryptorchidism on spermatogenesis. Fertil Steril. 1985;43:589–94.
Mieusset R, Bujan L, Mansat A, Pontonnier F, Grandjean H. Effects of artificial cryptorchidism on sperm morphology. Fertil Steril. 1987;47:150–5.
Mieusset R, Bujan L, Mansat A, Pontonnier F, Grandjean H. Hyperthermia and human spermatogenesis: enhancement of the inhibitory effect obtained by 'artificial cryptorchidism'. Int J Androl. 1987;10:571–80.
Hamada A, Kingsber S, Wierckx K, T'Sjoen G, De Sutter P, Knudson G, et al. Semen characteristics of transwomen referred for sperm banking before sex transition: a case series. Andrologia. 2015;47:832–8.
De Nie I, Meißner A, Kostelijk EH, Soufan AT, Voorn-de Warem IAC, den Heijer M, et al. Impaired semen quality in trans women: prevalence and determinants. Hum Reprod. 2020;35:1529–36.
Li K, Rodriguez D, Gabrielsen JS, Centola GM, Tanrikut C. Sperm cryopreservation of transgender individuals: trends and findings in the past decade. Andrology. 2018;6:860–4.
Marsh C, McCracken M, Gray M, Nangia A, Gay J, Roby KF. Low total motile sperm in transgender women seeking hormone therapy. J Assist Reprod Genet. 2019;36:1639–48.
Brik T, Vrouenraets LJJJ, Schagen SEE, Meissner A, de Vries MC, Hannema SE. Use of fertility preservation among a cohort of transgirls in the Netherlands. J Adolesc Health. 2019;64:589–93.
Barnard EP, Dhar CP, Rothenberg SS, Menke MN, Witchel SF, Montano GT, et al. Fertility preservation outcomes in adolescent and young adult feminizing transgender patients. Pediatrics. 2019;144:e20183943.
Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2010;16:231–45.
World Health Organization (2010) WHO laboratory manual for the examination and processing of human semen, 5th ed. World Health Organization. https://apps.who.int/iris/handle/10665/44261
Kruger TF, Acosta AA, Simmons KF, Swanson RJ, Matta JF, Oehninger S. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril. 1988;49:112–7.
Hezavehei M, Sharafi M, Kouchesfahani HM, Henkel R, Agarwal A, Esmaeili V, et al. Sperm cryopreservation: a review on current molecular cryobiology and advanced approaches. Reprod BioMed Online. 2018;37:327–39.
Hammadeh ME, Askari AS, Georg T, Rosenbaum P, Schmidt W. Effect of freeze-thawing procedure on chromatin stability, morphological alteration and membrane integrity of human spermatozoa in fertile and subfertile men. Int J Androl. 1999;22:155–62.
Blavier E, du Boulet B, Blion C, Bennaoum K, Rougier N, Tailland ML, et al. Fertility outcome after intracytoplasmic sperm injection with surgically retrieved sperm. J Gynecol Obstet Hum Reprod. 2020;101940. https://doi.org/10.1016/j.jogoh.2020.101940.
Wu H, Wang J, Cheng H, Gao Y, Liu W, Zhang Z, et al. Patients with severe asthenoteratospermia carrying SPAG6 or RSPH3 mutations have a positive pregnancy outcome following intracytoplasmic sperm injection. J Assist Reprod Genet. 2020;37:829–40.
Salmon-Divon M, Shrem G, Balayla J, Nehushtan T, Volodarsky-Perel A, Steiner N, et al. An age-based sperm nomogram: the McGill reference guide. Hum Reprod. 2020;35:2213–25.
van Casteren NJ, Boellaard WP, Romijn JC, Dohle GR. Gonadal dysfunction in male cancer patients before cytotoxic treatment. Int J Androl. 2010;33:73–9.
Amirjannati N, Sadeghi M, Hosseini Jadda SH, Ranjbar F, Kamali K, Akhondi MA. Evaluation of semen quality in patients with malignancies referred for sperm banking before cancer treatment. Andrologia. 2011;43:317–20.
Caponecchia L, Cimino G, Sacchetto R, Fiori C, Sebastianelli A, Salacone P, et al. Do malignant diseases affect semen quality? Sperm parameters of men with cancers. Andrologia. 2016;48:333–40.
Andersen AG, Jensen TK, Carlsen E, Jørgensen N, Andersson AM, Krarup T, et al. High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod. 2000;15:366–72.
Carlsen E, Swan SH, Petersen JH, Skakkebaek NE. Longitudinal changes in semen parameters in young Danish men from the Copenhagen area. Hum Reprod. 2005;20:942–9.
Kliesch S, Behre HM, Jürgens H, Nieschlag E. Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol. 1996;26:20–7.
Müller J, Sønksen J, Sommer P, Schmiegelow M, Petersen PM, Heilman C, et al. Cryopreservation of semen from pubertal boys with cancer. Med Pediatr Oncol. 2000;34:191–4.
Rey RA, Campo SM, Ropelato MG, Bergada I. Puberty: physiology and abnormalities. 1st ed. Berlin, Germany: Springer; 2016.
LabCorp and Endocrine SCIENCES (2019) Endocrinology expected values and S.I. unit conversion tables. https://www.endocrinesciences.com/sites/default/files/Endocrine%20Sciences%20Expected%20Values.pdf
Roxburgh A, Lea T, de Wit J, Degenhardt L. Sexual identity and prevalence of alcohol and other drug use among Australians in the general population. Int J Drug Policy. 2016;28:76–82.
Fontanari AMV, Pase PF, Churchill S, Soll BMB, Schwarz K, Schneider MA, et al. Dealing with gender-related and gender stress: substance use among Brazilian youth. Addict Behav Rep. 2019;9:100166.
Segev-Becker A, Israeli G, Elkon-Tamir E, Perl L, Sekler O, Amir H, et al. Children and adolescents with gender dysphoria in Israel; increasing referral and fertility preservation rates. Endocr Pract. 2020;26:423–8.
Thrower E, Bretherton I, Pang KC, Zajac JD, Cheung AS. Prevalence of autism spectrum disorder and attention-deficit hyperactivity disorder amongst individuals with gender dysphoria: a systematic review. J Autism Dev Disord. 2020;50:695–706.
Jurewicz J, Hanke W. Exposure to phthalates: reproductive outcome and children health. A review of epidemiological studies. Int J Occup Med Environ Health. 2011;24:115–41.
Patel B, Johnstone EB, Presson A, Zhang C, Jenkins T, Aston KI, et al. The effect of ADHD medications on semen analysis in sub-fertile couples. Fertil Steril. 2016;106:e234.
Harlev A, Henkel R, Samanta L, Agarwal A. Ritalinic acid stimulates human sperm motility and maintains vitality in vitro. World J Mens Health. 2020;38:61–7.
Connolly MD, Zervos MJ, Barone CJ, Johnson CC, Joseph CLM. The mental health of transgender youth: advances in understanding. J Adolesc Health. 2016;59:489–95.
Reisner SL, Vetters R, Leclerc M, Zaslow S, Wolfrum S, Shumer D, et al. Mental health of transgender youth in care at an adolescent urban community health center: a matched retrospective cohort study. J Adolesc Health. 2015;56:274–9.
Beeder LA, Samplaski MK. Effect of antidepressant medications on semen parameters and male fertility. Int J Urol. 2020;27:39–46.
Costabile RA, Spevak M. Cancer and male infertility. Oncology (Williston Park). 1998;12:557–62.
Vakalopoulos I, Dimou P, Anagnostou I, Zeginiadou T. Impact of cancer and cancer treatment on male fertility. Hormones (Athens). 2015;14:579–89.
Availability of Data and Material
Data are available upon request.
Code Availability
Not applicable.
Funding
No external funding was either sought or obtained for this study.
Author information
Authors and Affiliations
Contributions
H.A. was involved in the conception, study design, data acquisition and analysis, and manuscript preparation. A.O. and L.P. were involved in the conception, collected, and managed the database and provided their expertise in the critical reading of the manuscript. A.S.B. and G.I. collected the data and managed the database. S.B., D.L., and F.A. contributed in the interpretation of the data and provided their expertise in the critical reading of the manuscript. All contributors reviewed and edited the manuscript and gave their approval of the final version.
Corresponding author
Ethics declarations
Ethics Approval
This study was approved by the institutional review board (Helsinki) of the Tel Aviv Medical Center (#0405-20-TLV).
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Amir, H., Perl, L., Barda, S. et al. Adolescent Transgender Females Present Impaired Semen Quality That Is Suitable for Intracytoplasmic Sperm Injection Even Before Initiating Gender-Affirming Hormone Treatment. Reprod. Sci. 29, 260–269 (2022). https://doi.org/10.1007/s43032-021-00561-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43032-021-00561-y